The Division of Hematology and Hematological Malignancies will hold a research symposium to promote the many strengths of Hematologic research at the University of Utah and to foster interactions with other internal and external research groups. Opening remarks for the symposium will be given by Division Chief Michael Deininger, MD. The symposium will feature 20 internal speakers from a series of departments on campus and six external speakers who will share their expertise and insights. Dr. Ryan A Wilcox, University of Michigan: GATA-3 as a Novel Therapeutic Target in the T-cell Lymphomas: Do malignant T-cells GATA have it?
Confirmed External Speakers:
Dr. Mark Chiang, University of Michigan: Exploiting the context-dependence of Notch1 to develop safer therapy for T-cell leukemia
Dr. Ricardo Aguiar, University of Texas at San Antonio: New insights on DLBCL biology
Dr. Carlos A. Ramos, Baylor College of Medicine: CD30 CAR-T cells in Hematologic Malignancies
Dr. Daniel Pollyea, Univ CO: The Herculean Task of Targeting AML Stem Cells
Dr. John Welch, Washington Univ, St. Louis: Integrating next-generation sequencing into AML and MDS clinical trials
The symposium agenda includes the full lineup of speakers. The Hematology Research Symposium will be held June 8-9, 2018 at Deer Valley.